Literature DB >> 2848981

Non-genomic effects of estrogens and antiestrogens.

D J Weiss1, E Gurpide.   

Abstract

In addition to the effects of estrogens on transcription, mediated by the estrogen receptor, and the antiestrogenic effects of triphenylethylene derivatives resulting from their competitive action at the estrogen receptor level, estrogens and antiestrogens can affect cellular processes though other mechanisms. Estrogens can bind and alter enzymatic activities in membranes isolated from target cells, can influence the activities of purified enzymes and can change cell permeability and polarization under conditions excluding transcriptional effects. Triphenylethylene antiestrogens at micromolar concentrations can affect cholinergic, histaminergic and dopaminergic systems, affect calmodulin action and influence protein kinase C activity. Tamoxifen added to suspension of human endometrial adenocarcinoma cells at concentrations greater than 10 microM both increased phosphoinositide hydrolysis and inhibited the stimulatory effect of carbachol on this system. These effects, however, may represent nonspecific actions of the antiestrogens, shared with the structurally related phenothiazines, on the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848981     DOI: 10.1016/0022-4731(88)90017-9

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  13 in total

1.  Ratio of Circulating Estrogen Receptors Beta and Alpha (ERβ/ERα) Indicates Endoscopic Activity in Patients with Crohn's Disease.

Authors:  Pablo M Linares; Alicia Algaba; Ana Urzainqui; Mercedes Guijarro-Rojas; Rafael González-Tajuelo; Jesús Garrido; María Chaparro; Javier P Gisbert; Fernando Bermejo; Iván Guerra; Víctor Castellano; María-Encarnación Fernández-Contreras
Journal:  Dig Dis Sci       Date:  2017-08-19       Impact factor: 3.199

Review 2.  Sex-related factors in multiple sclerosis susceptibility and progression.

Authors:  Rhonda R Voskuhl; Stefan M Gold
Journal:  Nat Rev Neurol       Date:  2012-03-27       Impact factor: 42.937

3.  Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis.

Authors:  Allan J MacKenzie-Graham; Gilda A Rinek; Andrea Avedisian; Laurie B Morales; Elizabeth Umeda; Benoit Boulat; Russell E Jacobs; Arthur W Toga; Rhonda R Voskuhl
Journal:  J Neurosci Res       Date:  2012-03-13       Impact factor: 4.164

4.  Estrogen acidifies vaginal pH by up-regulation of proton secretion via the apical membrane of vaginal-ectocervical epithelial cells.

Authors:  George I Gorodeski; Ulrich Hopfer; Chung Chiun Liu; Ellen Margles
Journal:  Endocrinology       Date:  2004-10-21       Impact factor: 4.736

5.  Steroid hormone specifically binds to rat kidney plasma membrane.

Authors:  I Ibarrola; K Ogiza; A Marino; J M Macarulla; M Trueba
Journal:  J Bioenerg Biomembr       Date:  1991-12       Impact factor: 2.945

6.  Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats.

Authors:  Y P Dragan; S Fahey; K Street; J Vaughan; V C Jordan; H C Pitot
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Sex differences in autoimmune diseases.

Authors:  Rhonda Voskuhl
Journal:  Biol Sex Differ       Date:  2011-01-04       Impact factor: 5.027

8.  Tissue-Dependent Expression of Estrogen Receptor β in 17β-Estradiol-Mediated Attenuation of Autoimmune CNS Inflammation.

Authors:  Richard E Jones; Laurie Kaler; Stephanie Murphy; Halina Offner
Journal:  Open Autoimmun J       Date:  2010-01-01

9.  Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients.

Authors:  E A Lien; K Wester; P E Lønning; E Solheim; P M Ueland
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

10.  Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment.

Authors:  Seema Tiwari-Woodruff; Laurie Beth J Morales; Ruri Lee; Rhonda R Voskuhl
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.